We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results:1-10 of 166

State Telehealth Laws and Medicaid Policies: 50-State Survey Findings
  • Manatt Phelps & Phillips LLP
  • USA
  • July 10 2018

The use of telemedicine services is growing nationwide as providers and payors seek to improve access and better manage patient care, while reducing


GAO Report: Assisted Living Providers & Federal Regulation
  • Duane Morris LLP
  • USA
  • March 18 2018

On February 5, 2018, the Government Accountability Office, a nonpartisan investigative arm of Congress, found that there are huge gaps in regulation


Regulation A: For Smaller Companies (and ICOs) a Better Way to Go Public?
  • Pepper Hamilton LLP
  • USA
  • February 12 2018

With the proliferation of smaller companies seeking to grow their businesses, gain credibility and access capital, Regulation A is now increasingly


Platforms in the antitrust spotlight
  • Freshfields Bruckhaus Deringer
  • European Union
  • February 8 2018

As digital platforms continue to grow in social and economic importance, there can be no doubt about the ever brighter


HIPAA Annual Breach Report Deadline
  • Hall Benefits Law
  • USA
  • February 6 2018

The deadline for covered entities (i.e., health plans) to file their annual HIPAA breach reports with the U.S. Department of Health & Human Services


A Message to China? New U.S. Sanctions and AML Measures for North Korea
  • Pillsbury
  • USA, China
  • June 30 2017

On June 29, 2017, the U.S. Treasury Department announced new steps applying pressure on North Korea in relation to its proliferation activities


IPR Institution Denied Because Petitioner Used Hindsight Bias to Formulate Arguments
  • Marshall Gerstein & Borun LLP
  • USA
  • August 30 2016

On August 23, 2016, the PTAB denied Mylan Laboratories Limited's (Mylan) petition for IPR (IPR2016-00627) against a patent owned by Aventis Pharma S


Experimental evidence in patent cases: Discovery not available for experiments on matters no longer in issue
  • Corrs Chambers Westgarth
  • Australia
  • August 26 2016

In patent cases, it is not uncommon to conduct preliminary experiments on a confidential and privileged basis prior to deciding whether or not to


Drone Defenses, Part I: Rely on Local Law Enforcement
  • Pillsbury
  • USA
  • August 9 2016

The proliferation of drones, or unmanned aircraft systems (UAS), has resulted in a growing interest in preventing unlawful and potentially dangerous


FDA Releases Draft Guidance on Codevelopment of Therapeutic Products and Screening Tests
  • Mintz
  • USA
  • July 21 2016

On July 14, 2016, the U.S. Food and Drug Administration (the "FDA") released draft guidance on the codevelopment of therapeutic products (such as